Literature DB >> 20524514

Staging of lung cancer. Do we need a diagnostic CT of the brain after an integrated PET/CT for the detection of brain metastases?

W De Wever1, E Bruyeer, Ph Demaerel, G Wilms, J Coolen, J Verschakelen.   

Abstract

Brain CT has been recommended in staging of patients with lung cancer because of its usefulness in the detection of metastases. Purpose of this study is to examine if a diagnostic brain CT (CT,) can be obviated when an integrated PET/CT (PET/CT) is available. 87 consecutive patients underwent a diagnostic brain CT and a whole-body PET/CT within a period of 3 weeks to stage a known primary tumour. CT examinations were evaluated by two experienced neuroradiologists on the detection of brain lesions (benign and malignant). The results of PET/CT and CT reading were compared and both readings were compared with the clinical results. Statistical analysis was done by measuring sensitivity, specificity, PPV, NPV and accuracy. The relative accuracies were compared by a McNemar (exact) test for correlated proportions. Considering the CT, as standard of reference, sensitivity, specificity, PPV, NPV and accuracy for the brain CT of PET/CT (CT2) and PET/CT were respectively 83%, 96%, 77%, 97%, 94% and 69%, 98%, 90%, 95%, 94%. Considering the clinical diagnosis as standard of reference these figures were for CT1, CT2 and PET/CT respectively 80%, 100%, 100%, 96%, 96% and 66%, 95%, 77%, 93%, 90% and 66%, 97%, 83%, 93%, 91%. There was no statistical difference between CT1 and CT2. The comparison of the additional CT in PET/CT with a diagnostic CT of the brain did not yield a statistical difference in the detection of brain lesions despite the inferior quality of the CT component of PET/CT. A diagnostic brain CT can be obviated when a PET/CT is available.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20524514     DOI: 10.5334/jbr-btr.122

Source DB:  PubMed          Journal:  JBR-BTR        ISSN: 0302-7430


  4 in total

Review 1.  Positron emission tomography/computerized tomography in lung cancer.

Authors:  Ilgin Sahiner; Gulin Ucmak Vural
Journal:  Quant Imaging Med Surg       Date:  2014-06

2.  Risk factor of brain metastases and its influence on patient prognosis after complete resection of non-small cell lung cancer.

Authors:  Jinlei Li
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

3.  Inclusion of brain in FDG PET/CT scanning techniques in cancer patients: Does it obviate the need for dedicated brain imaging?

Authors:  Nilendu C Purandare
Journal:  Indian J Nucl Med       Date:  2011-04

4.  Functional dynamic contrast-enhanced magnetic resonance imaging in an animal model of brain metastases: a pilot study.

Authors:  Linfeng Zheng; Pengpeng Sun; Sujuan Zheng; Yuedong Han; Guixiang Zhang
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.